FIRST PHARMACOGENOMIC ANALYSIS USING WHOLE EXOME SEQUENCING TO IDENTIFY NOVEL GENETIC DETERMINANTS OF CLOPIDOGREL RESPONSE VARIABILITY: RESULTS OF THE GENOTYPE INFORMATION AND FUNCTIONAL TESTING (GIFT) EXOME STUDY

  • Price M
  • Carson A
  • Murray S
  • et al.
N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Although on-treatment reactivity (OTR) while receiving clopidogrel is strongly associated with CYP2C19 genotype, the majority of the hereditability in clopidogrel response variability remains unexplained, supporting the contention that other important genetic determinants have yet to be identified.

Cite

CITATION STYLE

APA

Price, M. J., Carson, A. R., Murray, S. S., Phillips, T., Janel, L., Tisch, R., … Levy, S. (2012). FIRST PHARMACOGENOMIC ANALYSIS USING WHOLE EXOME SEQUENCING TO IDENTIFY NOVEL GENETIC DETERMINANTS OF CLOPIDOGREL RESPONSE VARIABILITY: RESULTS OF THE GENOTYPE INFORMATION AND FUNCTIONAL TESTING (GIFT) EXOME STUDY. Journal of the American College of Cardiology, 59(13), E9. https://doi.org/10.1016/s0735-1097(12)60010-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free